Interstitial lung disease associated with oxaliplatin: description of two cases.
Pena Alvarez
C
C
Suh Oh
H J
HJ
Sáenz de Miera Rodríguez
A
A
García Arroyo
F R
FR
Covela Rúa
M
M
Salgado Boquete
L
L
López Clemente
P M
PM
Constenla Figueiras
M
M
D000230:Adenocarcinoma / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003110:Colonic Neoplasms / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil